KNTE
Kinnate Biopharma Inc
Price:  
2.65 
USD
Volume:  
2,812,220.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

KNTE Relative Valuation

-2609.8%
Upside

As of 2026-11-15, the Relative Valuation of Kinnate Biopharma Inc (KNTE) is (66.51) USD. This relative valuation is based on P/E multiples. With the latest stock price at 2.65 USD, the upside of Kinnate Biopharma Inc based on Relative Valuation is -2609.8%.

The range of the Relative Valuation is (62.57) - (72.74) USD.

Note: valuation result may not be accurate due to the company's negative earnings.

Range Selected
Trailing P/E multiples 25.4x - 31.3x 26.8x
Forward P/E multiples 26.2x - 30.5x 28.9x
Fair Price (62.57) - (72.74) (66.51)
Upside -2461.1% - -2845.0% -2609.8%
2.65 USD
Stock Price
(66.51) USD
Fair Price

KNTE Relative Valuation - Historical P/E Data

Date P/E